SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-066369
Filing Date
2018-11-06
Accepted
2018-11-06 17:01:05
Documents
3
Period of Report
2018-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-39442_28k.htm 8-K 24780
2 EX-99.1 a18-39442_2ex99d1.htm EX-99.1 111153
3 GRAPHIC g394422mm01i001.jpg GRAPHIC 3077
  Complete submission text file 0001104659-18-066369.txt   141568
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 181163817
SIC: 2836 Biological Products, (No Diagnostic Substances)